Quantamental Technologies LLC Neurocrine Biosciences Inc Transaction History

Quantamental Technologies LLC

  • $105 Million
  • Q3 2023

A detailed history of Quantamental Technologies LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quantamental Technologies LLC holds 1,846 shares of NBIX stock, worth $219,877. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,846
Holding current value
$219,877
% of portfolio
0.2%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $173,560 - $216,166
1,846 New
1,846 $207,000
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $212,782 - $278,148
2,261 New
2,261 $228,000
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $357,720 - $419,057
3,887 New
3,887 $413,000
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $246,909 - $323,112
-3,408 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $271,447 - $361,997
3,408 New
3,408 $290,000
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $378,929 - $573,919
-5,045 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $156,934 - $214,374
1,808 Added 55.85%
5,045 $542,000
Q3 2019

Nov 08, 2019
BUY
$83.82 - $101.5 $65,966 - $79,880
787 Added 32.12%
3,237 $292,000
Q2 2019

Aug 12, 2019
BUY
$72.24 - $91.27 $21,094 - $26,650
292 Added 13.53%
2,450 $207,000
Q1 2019

Apr 29, 2019
BUY
$69.31 - $91.53 $149,570 - $197,521
2,158 New
2,158 $190,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email